Ionis Pharmaceuticals (IONS) 8-K/A Summary

This amendment reports an Item 1.01 filing regarding an Advisory Services Agreement entered into with Richard Geary upon his retirement from the Company in January 2026.

• Advisory Period: January 16, 2026, through February 13, 2027.
• Compensation: Dr. Geary receives a flat fee of $300,000.
• Additional hourly compensation (\(400/hour over 16 hours weekly) applies, capped at a total maximum payout of **\)450,000**.

This filing updates a previous 8-K to include the Geary agreement as Exhibit 10.1. No financial performance